Cart
sales@molnova.com
Vibostolimab
CAS No. 2231305-30-7
Vibostolimab( —— )
Catalog No. M34759 CAS No. 2231305-30-7
Vibostolimab is a monoclonal antibody against T cell immune proteins and the ITIM domain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 347 | Get Quote |
|
| 5MG | 549 | Get Quote |
|
| 10MG | 882 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVibostolimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionVibostolimab is a monoclonal antibody against T cell immune proteins and the ITIM domain.
-
DescriptionVibostolimab is an anti-TIGIT (T cell immunoglobulin and ITIM domain) monoclonal antibody. Vibostolimab shows antitumor activity, and can be used in non-small cell lung cancer (NSCLC) and melanoma research.
-
In VitroVibostolimab binds to TIGIT and blocks the interaction between TIGIT and its ligands (CD112 and CD155), activating T lymphocytes which help to destroy tumor cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2231305-30-7
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Niu J, et al. First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆. Ann Oncol. 2022 Feb;33(2):169-180.?
molnova catalog
related products
-
Intermedine N-oxide
The herbs of Symphytum uplandicum.
-
KIRA6
KIRA6 is an effective inhibitor of IRE1α RNase kinase (IC50: 0.6 μM). It can trigger an apoptotic response.KIRA6 (10-1000 nM, 72 hours) strongly compromises the viability of the KIT-dependent cell line HMC-1.1 at the low nM concentration, in a manner that coincided with KIT blockade.
-
Bentiromide
Bentiromide is a peptide used in the bentiromide test to monitor the adequacy of supplemental pancreatic therapy and to screen exocrine pancreatic insufficiency.
